University of Colorado scientists have begun research on the medicinal benefits of using the chemical compound CBD to help treat Eczema and Psoriasis. Eczema is a condition that can causes terrible rashes throughout your body, and Psoriasis, which causes skin cells to build up and form dry patches and rashes.
The University of Colorado hopes that research into using the chemical compound, Cannabidiol (CBD), as a topical relief can offer hope for millions of people that suffer from skin related conditions.
CBD, is distinctly different than THC, because it is a non-psychoactive chemical compound . It is one of many different compounds that can be extracted from the cannabis and industrial hemp plant but, is naturally found in higher concentrations in hemp.
Cannabidiol has gained lots of attention in the media as of late. The World Health Organization recently determined that CBD has, “been demonstrated as an effective treatment for epilepsy in adults, children, and even animals, and that there’s preliminary evidence that CBD could be useful in treating Alzheimer’s disease, cancer, psychosis, Parkinson’s disease, and other serious conditions.”
Though CBD has not been officially recognized to contain medicinal benefits, millions of CBD product are being sold every month around the world. The more research that is conduction by educational institutions on the benefits of CBD, the more legislation in countries like the United States will begin to favor legalization of the compound for medicinal use.
You may be interested
MedMen to Sell Three Retail Locations to Treehouse Real Estate for $12.5MEditor - October 19, 2018
MedMen Enterprises Inc. (CSE: MMEN) (OTCQB: MMNFF) announced this week that the company has agreed to sell three seperate cannabis retail locations to Treehouse Real Estate Investment…
CashCropToday | 411/420 | Cannapreneur Bo Money Discusses Events For Social Equity Plan (Part 3)Jaelynn Offerman - October 18, 2018
Host Joya Italiano continues her discussion with cannapreneur and social equity advocate, Bo Money. Bo reveals upcoming plans stored in place and discusses the reasoning behind the…
Public Companies iAnthus & MPX Bioceutical Announce Official MergerEditor - October 18, 2018
iAnthus Capital Holdings, Inc. (CSE: IAN) (OTCQX: ITHUF), and MPX Bioceutical Corporation (CSE: MPX) (OTC: MPXEF) have announced this morning that the companies signed an agreement to merge…